In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species

Jose Antonio Vazquez, Maria Lynch, Dina Boikov, Jack D. Sobel

Research output: Contribution to journalArticle

107 Scopus citations

Abstract

The in vitro activity of a new pneumocandin, L-743,872, was evaluated with 108 strains of Candida and compared with the activities of various antifungals. L-743,872 demonstrated the best activity against azole- susceptible and -resistant strains of C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, and C. kefyr and less activity against C. krusei, C. lusitaniae, and C. guilliermondii.

Original languageEnglish (US)
Pages (from-to)1612-1614
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume41
Issue number7
StatePublished - Jul 1 1997
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this